Mylan CFO jetting off to Israel for stock exchange meeting: Reuters

Mylan ($MYL) is sending its CFO, John Sheehan, on the road in Israel. That's the home country of its spurned suitor Teva ($TEVA), but it's also one place where its takeover target Perrigo ($PRGO) is publicly listed. Accoding to Reuters, Sheehan will meet with the head of the Tel Aviv Stock Exchange about listing Mylan there if it succeeds in buying the OTC drugmaker. He might also meet with some institutional investors in the country. Report

Suggested Articles

AbbVie has seen blossoming market share for immunology launches Rinvoq and Skyrizi—and it's eyeing Allergan's neurology biz for a boost, too.

While Novo's Rybelsus launch has slowed due to the pandemic, another version of the med, Ozempic posted strong sales.

AZ sold Atacand and Atacand Plus rights in about 70 countries to Cheplapharm.